Skip to content

KeyZell Start-Up Plans to Reach 5 million Euros in Private Investment and Become the new Biotech Unicorn

By asianet

KeyZell, a Spanish biotechnology company in the development phase of digital cancer treatments and tools, has just opened a private financing round which expects to achieve 5 million euros to boost its projects and consolidate itself as one of the biotech start-ups with the greatest international projection. KeyZell launches this new round of private investment … Continued

Evercare Group launches Evercare Foundation to help bridge the gap in inequality in healthcare

By asianet

– The Foundation will provide long-term solutions to improve healthcare access in Africa and South Asia, while contributing to the 2030 Sustainable Development Goals. The Evercare Group today announced the launch of the Evercare Foundation, a non-profit organization working towards equitable health for all and the development of more resilient health systems across the low- … Continued

Instylla First-In-Human Clinical Trial Published Results Demonstrate Technical Success and Persistent Embolization Across All Patients

By asianet

–Prospective multicenter study evaluated the safety and efficacy of a PEG-based liquid embolic in treating hypervascular tumors Instylla, Inc. ( https://instylla.com ), a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the publication of results (i) ( https://c212.net/c/link/?t=0&l=en&o=3472026-1&h=2141884526&u=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS1051044322001117%3Fvia%253Dihub&a=publication+of+results ) from the first-in-human clinical trial of Embrace (TM) Hydrogel Embolic System … Continued

European Wellness Biomedical Group and AK International to Bring Biological Regenerative Medicine Solutions to Pakistan and UAE

By asianet

European Wellness Biomedical Group (EWBG) has signed a Memorandum of Agreement (MOA) with Dubai-based AK International LLC (AKI), partnering together to undertake a number of joint venture businesses in Pakistan and the MENA region that focus on providing biological regenerative medicine services and solutions to the community. In the signing session held on 1st March … Continued

Indonesia Puts Strict Health Protocols for G20 Summit, Highlights the Importance of Pandemic Preparedness

By asianet

On track to host the G20 summit in Bali on November 15-16, The Indonesia’s Ministry of Health is set to implement a strict health protocol system as a precaution against COVID-19. The system will serve as a guideline for every activity during the summit. The Indonesian G20 presidency’s overarching theme is “Recover Together, Recover Stronger,” … Continued

Guardant Health Receives Regulatory Approval for Guardant360 CDx in Japan

By asianet

Guardant360(R) CDx is a comprehensive genomic profiling test which utilizes blood samples from patients with advanced solid cancers The Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval of Guardant360(R) CDx, a liquid biopsy test for tumor mutation profiling, also known as comprehensive genomic profiling (CGP), in patients with advanced solid cancers. The … Continued

SIFI Announces the Grant of a Second FDA Orphan Drug Designation for Polihexanide in Fungal Keratitis

By asianet

This follows the previously-granted ODD for polihexanide in Acanthamoeba Keratitis by the FDA and EMA. An estimated 15,660 patients with fungal keratitis are diagnosed annually in the US. SIFI S.p.A. (“SIFI” or the “Company”), a leading international ophthalmic pharmaceutical company, announced today that the U.S. Food and Drug Administration (“FDA”) has approved the company’s Orphan … Continued

Novavax Announces Launch of Global Vaccine Education Programs

By asianet

– ‘We Do Vaccines’ and ‘Know Our Vax’ are new educational efforts that provide information regarding vaccines – Programs explain Novavax’ commitment to vaccine development and innovation Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the launch of its global unbranded ‘We Do … Continued

Gan & Lee Pharmaceuticals Begins First-In-Human Trial in U.S. for Investigational Drug, GZR18

By asianet

Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is pleased to announce the first subject has been dosed in our Phase I, double-blinded, randomized, placebo-controlled, sequential, single, ascending dose clinical study in the U.S. for the company’s investigational drug, GZR18. GZR18 is a glucagon-like peptide-1 receptor agonist … Continued